Vigilio Ballabeni - Search Results

Year	Number of Results
2002	5
2003	4
2004	4
2005	5
2006	7
2007	7
2008	5
2009	3
2010	3
2011	2
2012	3
2013	1
2014	4
2015	2
2016	1
2017	3
2018	2
2020	2
2022	1
2023	2
2024	0

1

Mesenteric ischemia-reperfusion: an overview of preclinical drug strategies.

Bertoni S, Ballabeni V, Barocelli E, Tognolini M. Bertoni S, et al. Among authors: ballabeni v. Drug Discov Today. 2018 Jul;23(7):1416-1425. doi: 10.1016/j.drudis.2018.05.034. Epub 2018 May 29. Drug Discov Today. 2018. PMID: 29857163 Review.

2

Pharmacological characterization of second generation FXR agonists as effective EphA2 antagonists: A successful application of target hopping approach.

Ferrari FR, Giorgio C, Zappia A, Ballabeni V, Bertoni S, Barocelli E, Scalvini L, Galvani F, Mor M, Lodola A, Tognolini M. Ferrari FR, et al. Among authors: ballabeni v. Biochem Pharmacol. 2023 Mar;209:115452. doi: 10.1016/j.bcp.2023.115452. Epub 2023 Feb 13. Biochem Pharmacol. 2023. PMID: 36792038

3

Gastric motor dysfunctions in Parkinson's disease: Current pre-clinical evidence.

Pellegrini C, Antonioli L, Colucci R, Ballabeni V, Barocelli E, Bernardini N, Blandizzi C, Fornai M. Pellegrini C, et al. Among authors: ballabeni v. Parkinsonism Relat Disord. 2015 Dec;21(12):1407-14. doi: 10.1016/j.parkreldis.2015.10.011. Epub 2015 Oct 21. Parkinsonism Relat Disord. 2015. PMID: 26499757 Review.

4

Impact of S1P Mimetics on Mesenteric Ischemia/Reperfusion Injury.

Potì F, Giorgio C, Zini I, Nofer JR, Vivo V, Palese S, Ballabeni V, Barocelli E, Bertoni S. Potì F, et al. Among authors: ballabeni v. Pharmaceuticals (Basel). 2020 Oct 9;13(10):298. doi: 10.3390/ph13100298. Pharmaceuticals (Basel). 2020. PMID: 33050288 Free PMC article.

5

Discovery of small-molecules targeting the CCL20/CCR6 axis as first-in-class inhibitors for inflammatory bowel diseases.

Martina MG, Giorgio C, Allodi M, Palese S, Barocelli E, Ballabeni V, Szpakowska M, Chevigné A, Piet van Hamburg J, Davelaar N, Lubberts E, Bertoni S, Radi M. Martina MG, et al. Among authors: ballabeni v. Eur J Med Chem. 2022 Dec 5;243:114703. doi: 10.1016/j.ejmech.2022.114703. Epub 2022 Aug 29. Eur J Med Chem. 2022. PMID: 36067700

6

Pharmacological evaluation of new bioavailable small molecules targeting Eph/ephrin interaction.

Giorgio C, Incerti M, Corrado M, Rusnati M, Chiodelli P, Russo S, Callegari D, Ferlenghi F, Ballabeni V, Barocelli E, Lodola A, Tognolini M. Giorgio C, et al. Among authors: ballabeni v. Biochem Pharmacol. 2018 Jan;147:21-29. doi: 10.1016/j.bcp.2017.11.002. Epub 2017 Nov 10. Biochem Pharmacol. 2018. PMID: 29129483

7

Histamine in the control of gastric acid secretion: a topic review.

Barocelli E, Ballabeni V. Barocelli E, et al. Among authors: ballabeni v. Pharmacol Res. 2003 Apr;47(4):299-304. doi: 10.1016/s1043-6618(03)00009-4. Pharmacol Res. 2003. PMID: 12644386 Review.

8

Protection by the Eph-Ephrin System Against Mesenteric Ischemia-Reperfusion Injury.

Vivo V, Zini I, Cantoni AM, Grandi A, Tognolini M, Castelli R, Ballabeni V, Bertoni S, Barocelli E. Vivo V, et al. Among authors: ballabeni v. Shock. 2017 Dec;48(6):681-689. doi: 10.1097/SHK.0000000000000890. Shock. 2017. PMID: 28472014

9

Probing the effects of MR120 in preclinical chronic colitis: A first-in-class anti-IBD agent targeting the CCL20/CCR6 axis.

Allodi M, Giorgio C, Incerti M, Corradi D, Flammini L, Ballabeni V, Barocelli E, Radi M, Bertoni S. Allodi M, et al. Among authors: ballabeni v. Eur J Pharmacol. 2023 Apr 15;945:175613. doi: 10.1016/j.ejphar.2023.175613. Epub 2023 Feb 24. Eur J Pharmacol. 2023. PMID: 36841282 Free article.

10

Optimization of EphA2 antagonists based on a lithocholic acid core led to the identification of UniPR505, a new 3α-carbamoyloxy derivative with antiangiogenetic properties.

Incerti M, Russo S, Corrado M, Giorgio C, Ballabeni V, Chiodelli P, Rusnati M, Scalvini L, Callegari D, Castelli R, Vacondio F, Ferlenghi F, Tognolini M, Lodola A. Incerti M, et al. Among authors: ballabeni v. Eur J Med Chem. 2020 Mar 1;189:112083. doi: 10.1016/j.ejmech.2020.112083. Epub 2020 Jan 22. Eur J Med Chem. 2020. PMID: 32000051

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

53 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year